- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Market Overview
The global Opioid Induced Constipation Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Opioid Induced Constipation Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Opioid Induced Constipation Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Opioid Induced Constipation Drugs market has been segmented into Lubiprostone, Methyl Naltrexone Bromide, Naldemedine, Alvimopan, Other, etc.
Breakdown by Application, Opioid Induced Constipation Drugs has been segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Opioid Induced Constipation Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Opioid Induced Constipation Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Opioid Induced Constipation Drugs market.
For United States, this report analyses the United States market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and Opioid Induced Constipation Drugs Market Share Analysis
Opioid Induced Constipation Drugs competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Opioid Induced Constipation Drugs revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Opioid Induced Constipation Drugs revenue and market share for each player covered in this report.
The major players covered in Opioid Induced Constipation Drugs are: Ironwood Pharmaceuticals Inc, Purdue Pharma, Progenics Pharmaceuticals Inc, Daiichi Sankyo Co Ltd, Nektar Therapeutics, Pfizer, Mundipharma International Limited, Allergan Plc, Shionogi & Co., Ltd, S.L.A. Pharma AG, Cosmo Pharmaceuticals SA, Sucampo Pharmaceuticals, Ono Pharmaceutical Co., Ltd, Daewoong Pharmaceutical, Bausch Health, Takeda Pharmaceutical Company Limited, C.B. Fleet Company, Theravance Biopharma Inc, etc. Among other players domestic and global, Opioid Induced Constipation Drugs market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Market segment by players, this report covers
Ironwood Pharmaceuticals Inc
Purdue Pharma
Progenics Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Nektar Therapeutics
Pfizer
Mundipharma International Limited
Allergan Plc
Shionogi & Co., Ltd
S.L.A. Pharma AG
Cosmo Pharmaceuticals SA
Sucampo Pharmaceuticals
Ono Pharmaceutical Co., Ltd
Daewoong Pharmaceutical
Bausch Health
Takeda Pharmaceutical Company Limited
C.B. Fleet Company
Theravance Biopharma Inc
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
MENA (Saudi Arabia, UAE, Turkey and South Africa)
Market segment by Type, covers:
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Other
Market segment by Application, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Opioid Induced Constipation Drugs
1.2 Classification of Opioid Induced Constipation Drugs by Type
1.2.1 Overview: Global Opioid Induced Constipation Drugs Revenue by Type: 2015 Versus 2019 Versus 2025
1.2.2 Global Opioid Induced Constipation Drugs Revenue Market Share by Type in 2019
1.2.3 Lubiprostone
1.2.4 Methyl Naltrexone Bromide
1.2.5 Naldemedine
1.2.6 Alvimopan
1.2.7 Other
1.3 Global Opioid Induced Constipation Drugs Market by Application
1.3.1 Overview: Global Opioid Induced Constipation Drugs Revenue by Application: 2015 Versus 2019 Versus 2025
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Opioid Induced Constipation Drugs Market Size and Forecast (2015-2025)
1.5 Global Opioid Induced Constipation Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.6 Global Opioid Induced Constipation Drugs Market Size by Regions (2015-2020)
1.7 Global Opioid Induced Constipation Drugs Market Size and Forecast by Regions (2020-2025)
1.7.1 North America Opioid Induced Constipation Drugs Status and Prospect (2015-2025)
1.7.2 Europe Opioid Induced Constipation Drugs Status and Prospect (2015-2025)
1.7.3 Asia Opioid Induced Constipation Drugs Status and Prospect (2015-2025)
1.7.4 South America Opioid Induced Constipation Drugs Status and Prospect (2015-2025)
1.7.5 Middle East & Africa Opioid Induced Constipation Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Ironwood Pharmaceuticals Inc
2.1.1 Ironwood Pharmaceuticals Inc Details
2.1.2 Ironwood Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Ironwood Pharmaceuticals Inc SWOT Analysis
2.1.4 Ironwood Pharmaceuticals Inc Product and Services
2.1.5 Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Purdue Pharma
2.2.1 Purdue Pharma Details
2.2.2 Purdue Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Purdue Pharma SWOT Analysis
2.2.4 Purdue Pharma Product and Services
2.2.5 Purdue Pharma Opioid Induced Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 Progenics Pharmaceuticals Inc
2.3.1 Progenics Pharmaceuticals Inc Details
2.3.2 Progenics Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Progenics Pharmaceuticals Inc SWOT Analysis
2.3.4 Progenics Pharmaceuticals Inc Product and Services
2.3.5 Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 Daiichi Sankyo Co Ltd
2.4.1 Daiichi Sankyo Co Ltd Details
2.4.2 Daiichi Sankyo Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Daiichi Sankyo Co Ltd SWOT Analysis
2.4.4 Daiichi Sankyo Co Ltd Product and Services
2.4.5 Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 Nektar Therapeutics
2.5.1 Nektar Therapeutics Details
2.5.2 Nektar Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Nektar Therapeutics SWOT Analysis
2.5.4 Nektar Therapeutics Product and Services
2.5.5 Nektar Therapeutics Opioid Induced Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer SWOT Analysis
2.6.4 Pfizer Product and Services
2.6.5 Pfizer Opioid Induced Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 Mundipharma International Limited
2.7.1 Mundipharma International Limited Details
2.7.2 Mundipharma International Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Mundipharma International Limited SWOT Analysis
2.7.4 Mundipharma International Limited Product and Services
2.7.5 Mundipharma International Limited Opioid Induced Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.8 Allergan Plc
2.8.1 Allergan Plc Details
2.8.2 Allergan Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Allergan Plc SWOT Analysis
2.8.4 Allergan Plc Product and Services
2.8.5 Allergan Plc Opioid Induced Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.9 Shionogi & Co., Ltd
2.9.1 Shionogi & Co., Ltd Details
2.9.2 Shionogi & Co., Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Shionogi & Co., Ltd SWOT Analysis
2.9.4 Shionogi & Co., Ltd Product and Services
2.9.5 Shionogi & Co., Ltd Opioid Induced Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.10 S.L.A. Pharma AG
2.10.1 S.L.A. Pharma AG Details
2.10.2 S.L.A. Pharma AG Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 S.L.A. Pharma AG SWOT Analysis
2.10.4 S.L.A. Pharma AG Product and Services
2.10.5 S.L.A. Pharma AG Opioid Induced Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.11 Cosmo Pharmaceuticals SA
2.11.1 Cosmo Pharmaceuticals SA Details
2.11.2 Cosmo Pharmaceuticals SA Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Cosmo Pharmaceuticals SA SWOT Analysis
2.11.4 Cosmo Pharmaceuticals SA Product and Services
2.11.5 Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.12 Sucampo Pharmaceuticals
2.12.1 Sucampo Pharmaceuticals Details
2.12.2 Sucampo Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Sucampo Pharmaceuticals SWOT Analysis
2.12.4 Sucampo Pharmaceuticals Product and Services
2.12.5 Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.13 Ono Pharmaceutical Co., Ltd
2.13.1 Ono Pharmaceutical Co., Ltd Details
2.13.2 Ono Pharmaceutical Co., Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Ono Pharmaceutical Co., Ltd SWOT Analysis
2.13.4 Ono Pharmaceutical Co., Ltd Product and Services
2.13.5 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.14 Daewoong Pharmaceutical
2.14.1 Daewoong Pharmaceutical Details
2.14.2 Daewoong Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Daewoong Pharmaceutical SWOT Analysis
2.14.4 Daewoong Pharmaceutical Product and Services
2.14.5 Daewoong Pharmaceutical Opioid Induced Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.15 Bausch Health
2.15.1 Bausch Health Details
2.15.2 Bausch Health Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Bausch Health SWOT Analysis
2.15.4 Bausch Health Product and Services
2.15.5 Bausch Health Opioid Induced Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.16 Takeda Pharmaceutical Company Limited
2.16.1 Takeda Pharmaceutical Company Limited Details
2.16.2 Takeda Pharmaceutical Company Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Takeda Pharmaceutical Company Limited SWOT Analysis
2.16.4 Takeda Pharmaceutical Company Limited Product and Services
2.16.5 Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.17 C.B. Fleet Company
2.17.1 C.B. Fleet Company Details
2.17.2 C.B. Fleet Company Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 C.B. Fleet Company SWOT Analysis
2.17.4 C.B. Fleet Company Product and Services
2.17.5 C.B. Fleet Company Opioid Induced Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.18 Theravance Biopharma Inc
2.18.1 Theravance Biopharma Inc Details
2.18.2 Theravance Biopharma Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Theravance Biopharma Inc SWOT Analysis
2.18.4 Theravance Biopharma Inc Product and Services
2.18.3 Theravance Biopharma Inc Opioid Induced Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Opioid Induced Constipation Drugs Market Size by Players (2015-2020)
3.2 United States Opioid Induced Constipation Drugs Market Size by Players (2015-2020)
3.3 Market Concentration Rate
3.3.1 Top 5 Opioid Induced Constipation Drugs Players Market Share
3.3.2 Top 10 Opioid Induced Constipation Drugs Players Market Share
4 North America Market Size and Forecast by Countries
4.1 North America Opioid Induced Constipation Drugs Market Size by Countries (2015-2020)
4.2 North America Opioid Induced Constipation Drugs Market Size and Forecast by Countries (2015-2026)
4.3 United States Opioid Induced Constipation Drugs Market Size and Forecast (2015-2025)
4.4 Canada Opioid Induced Constipation Drugs Market Size and Forecast (2015-2025)
4.5 Mexico Opioid Induced Constipation Drugs Market Size and Forecast (2015-2025)
5 Europe Market Size and Forecast by Countries
5.1 Europe Opioid Induced Constipation Drugs Market Size by Countries (2015-2020)
5.2 Europe Opioid Induced Constipation Drugs Market Size and Forecast by Countries (2015-2026)
5.3 Germany Opioid Induced Constipation Drugs Market Size and Forecast (2015-2025)
5.4 France Opioid Induced Constipation Drugs Market Size and Forecast (2015-2025)
5.5 UK Opioid Induced Constipation Drugs Market Size and Forecast (2015-2025)
5.6 Russia Opioid Induced Constipation Drugs Market Size and Forecast (2015-2025)
5.7 Italy Opioid Induced Constipation Drugs Market Size and Forecast (2015-2025)
6 Asia-Pacific Market Size and Forecast by Countries
6.1 Asia-Pacific Opioid Induced Constipation Drugs Market Size by Regions (2015-2020)
6.2 Asia-Pacific Opioid Induced Constipation Drugs Market Size and Forecast by Regions (2015-2026)
6.3 China Opioid Induced Constipation Drugs Market Size and Forecast (2015-2025)
6.4 Japan Opioid Induced Constipation Drugs Market Size and Forecast (2015-2025)
6.5 Korea Opioid Induced Constipation Drugs Market Size and Forecast (2015-2025)
6.6 India Opioid Induced Constipation Drugs Market Size and Forecast (2015-2025)
6.7 Southeast Asia Opioid Induced Constipation Drugs Market Size and Forecast (2015-2025)
7 South America Market Size and Forecast by Countries
7.1 South America Opioid Induced Constipation Drugs Market Size by Countries (2015-2020)
7.2 South America Opioid Induced Constipation Drugs Market Size and Forecast by Countries (2015-2026)
7.3 Brazil Opioid Induced Constipation Drugs Market Size and Forecast (2015-2025)
7.4 Argentina Opioid Induced Constipation Drugs Market Size and Forecast (2015-2025)
8 Middle East & Africa Market Size and Forecast by Countries
8.1 Middle East & Africa Opioid Induced Constipation Drugs Revenue by Regions (2015-2020)
8.2 Middle East & Africa Opioid Induced Constipation Drugs Market Size and Forecast by Countries (2015-2026)
8.3 Saudi Arabia Opioid Induced Constipation Drugs Market Size and Forecast (2015-2025)
8.4 UAE Opioid Induced Constipation Drugs Market Size and Forecast (2015-2025)
8.5 Egypt Opioid Induced Constipation Drugs Market Size and Forecast (2015-2025)
8.6 South Africa Opioid Induced Constipation Drugs Market Size and Forecast (2015-2025)
9 Market Size Segment by Type
9.1 Global Opioid Induced Constipation Drugs Market Size and Forecast by Type (2015-2025)
9.1.1 Global Opioid Induced Constipation Drugs Market Size by Type (2015-2020)
9.1.2 Global Opioid Induced Constipation Drugs Market Size Forecast by Type (2020-2025)
9.2 United States Opioid Induced Constipation Drugs Market Size and Forecast by Type (2015-2025)
9.2.1 United States Opioid Induced Constipation Drugs Market Size by Type (2015-2020)
9.2.2 United States Opioid Induced Constipation Drugs Market Size Forecast by Type (2020-2025)
10 Market Size Segment by Application
10.1 Global Opioid Induced Constipation Drugs Market Size and Forecast by Application (2015-2025)
10.1.1 Global Opioid Induced Constipation Drugs Market Size by Application (2015-2020)
10.1.2 Global Opioid Induced Constipation Drugs Market Size Forecast by Application (2020-2025)
10.2 United States Opioid Induced Constipation Drugs Market Size and Forecast by Application (2015-2025)
10.2.1 United States Opioid Induced Constipation Drugs Market Size by Application (2015-2020)
10.2.2 United States Opioid Induced Constipation Drugs Market Size Forecast by Application (2020-2025)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Data Source
12.3 Disclaimer
12.4 About US
List of Tables
Table 1. Global Opioid Induced Constipation Drugs Revenue (USD Million) by Type: 2015 Versus 2019 Versus 2025
Table 2. Breakdown of Opioid Induced Constipation Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Opioid Induced Constipation Drugs Revenue (USD Million) by Application: 2015 Versus 2019 Versus 2025
Table 4. Global Market Opioid Induced Constipation Drugs Market Size (USD Million) Comparison by Regions (2020-2025)
Table 5. Global Opioid Induced Constipation Drugs Revenue (USD Million) by Regions (2015-2020)
Table 6. Global Opioid Induced Constipation Drugs Revenue Share by Regions (2015-2020)
Table 7. Global Opioid Induced Constipation Drugs Revenue (USD Million) by Regions (2020-2025)
Table 8. Global Opioid Induced Constipation Drugs Revenue Market Share by Regions (2020-2025)
Table 9. Ironwood Pharmaceuticals Inc Corporate Information, Location and Competitors
Table 10. Ironwood Pharmaceuticals Inc Major Business
Table 11. Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 12. Ironwood Pharmaceuticals Inc SWOT Analysis
Table 13. Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Product and Solutions
Table 14. Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 15. Purdue Pharma Corporate Information, Location and Competitors
Table 16. Purdue Pharma Major Business
Table 17. Purdue Pharma Opioid Induced Constipation Drugs Total Revenue (USD Million) (2018-2019)
Table 18. Purdue Pharma SWOT Analysis
Table 19. Purdue Pharma Opioid Induced Constipation Drugs Product and Solutions
Table 20. Purdue Pharma Opioid Induced Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 21. Progenics Pharmaceuticals Inc Corporate Information, Location and Competitors
Table 22. Progenics Pharmaceuticals Inc Major Business
Table 23. Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 24. Progenics Pharmaceuticals Inc SWOT Analysis
Table 25. Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Product and Solutions
Table 26. Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 27. Daiichi Sankyo Co Ltd Corporate Information, Location and Competitors
Table 28. Daiichi Sankyo Co Ltd Major Business
Table 29. Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 30. Daiichi Sankyo Co Ltd SWOT Analysis
Table 31. Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Product and Solutions
Table 32. Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 33. Nektar Therapeutics Corporate Information, Location and Competitors
Table 34. Nektar Therapeutics Major Business
Table 35. Nektar Therapeutics Opioid Induced Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 36. Nektar Therapeutics SWOT Analysis
Table 37. Nektar Therapeutics Opioid Induced Constipation Drugs Product and Solutions
Table 38. Nektar Therapeutics Opioid Induced Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 39. Pfizer Corporate Information, Location and Competitors
Table 40. Pfizer Major Business
Table 41. Pfizer Opioid Induced Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 42. Pfizer SWOT Analysis
Table 43. Pfizer Opioid Induced Constipation Drugs Product and Solutions
Table 44. Pfizer Opioid Induced Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 45. Mundipharma International Limited Corporate Information, Location and Competitors
Table 46. Mundipharma International Limited Major Business
Table 47. Mundipharma International Limited Opioid Induced Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 48. Mundipharma International Limited SWOT Analysis
Table 49. Mundipharma International Limited Opioid Induced Constipation Drugs Product and Solutions
Table 50. Mundipharma International Limited Opioid Induced Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 51. Allergan Plc Corporate Information, Location and Competitors
Table 52. Allergan Plc Major Business
Table 53. Allergan Plc Opioid Induced Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 54. Allergan Plc SWOT Analysis
Table 55. Allergan Plc Opioid Induced Constipation Drugs Product and Solutions
Table 56. Allergan Plc Opioid Induced Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 57. Shionogi & Co., Ltd Corporate Information, Location and Competitors
Table 58. Shionogi & Co., Ltd Major Business
Table 59. Shionogi & Co., Ltd Opioid Induced Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 60. Shionogi & Co., Ltd SWOT Analysis
Table 61. Shionogi & Co., Ltd Opioid Induced Constipation Drugs Product and Solutions
Table 62. Shionogi & Co., Ltd Opioid Induced Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 63. S.L.A. Pharma AG Corporate Information, Location and Competitors
Table 64. S.L.A. Pharma AG Major Business
Table 65. S.L.A. Pharma AG Opioid Induced Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 66. S.L.A. Pharma AG SWOT Analysis
Table 67. S.L.A. Pharma AG Opioid Induced Constipation Drugs Product and Solutions
Table 68. S.L.A. Pharma AG Opioid Induced Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 69. Cosmo Pharmaceuticals SA Corporate Information, Location and Competitors
Table 70. Cosmo Pharmaceuticals SA Major Business
Table 71. Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 72. Cosmo Pharmaceuticals SA SWOT Analysis
Table 73. Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Product and Solutions
Table 74. Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 75. Sucampo Pharmaceuticals Corporate Information, Location and Competitors
Table 76. Sucampo Pharmaceuticals Major Business
Table 77. Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 78. Sucampo Pharmaceuticals SWOT Analysis
Table 79. Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Product and Solutions
Table 80. Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 81. Ono Pharmaceutical Co., Ltd Corporate Information, Location and Competitors
Table 82. Ono Pharmaceutical Co., Ltd Major Business
Table 83. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 84. Ono Pharmaceutical Co., Ltd SWOT Analysis
Table 85. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Product and Solutions
Table 86. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 87. Daewoong Pharmaceutical Corporate Information, Location and Competitors
Table 88. Daewoong Pharmaceutical Major Business
Table 89. Daewoong Pharmaceutical Opioid Induced Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 90. Daewoong Pharmaceutical SWOT Analysis
Table 91. Daewoong Pharmaceutical Opioid Induced Constipation Drugs Product and Solutions
Table 92. Daewoong Pharmaceutical Opioid Induced Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 93. Bausch Health Corporate Information, Location and Competitors
Table 94. Bausch Health Major Business
Table 95. Bausch Health Opioid Induced Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 96. Bausch Health SWOT Analysis
Table 97. Bausch Health Opioid Induced Constipation Drugs Product and Solutions
Table 98. Bausch Health Opioid Induced Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 99. Takeda Pharmaceutical Company Limited Corporate Information, Location and Competitors
Table 100. Takeda Pharmaceutical Company Limited Major Business
Table 101. Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 102. Takeda Pharmaceutical Company Limited SWOT Analysis
Table 103. Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Product and Solutions
Table 104. Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 105. C.B. Fleet Company Corporate Information, Location and Competitors
Table 106. C.B. Fleet Company Major Business
Table 107. C.B. Fleet Company Opioid Induced Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 108. C.B. Fleet Company SWOT Analysis
Table 109. C.B. Fleet Company Opioid Induced Constipation Drugs Product and Solutions
Table 110. C.B. Fleet Company Opioid Induced Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 111. Theravance Biopharma Inc Opioid Induced Constipation Drugs Type and Application
Table 112. Theravance Biopharma Inc Major Business
Table 113. Theravance Biopharma Inc Opioid Induced Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 114. Theravance Biopharma Inc SWOT Analysis
Table 115. Theravance Biopharma Inc Opioid Induced Constipation Drugs Product and Solutions
Table 116. Theravance Biopharma Inc Opioid Induced Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 117. Global Opioid Induced Constipation Drugs Revenue (USD Million) by Players (2015-2020)
Table 118. Global Opioid Induced Constipation Drugs Revenue Share by Players (2015-2020)
Table 119. Key Players Opioid Induced Constipation Drugs Revenue (USD Million) in United States (2015-2020)
Table 120. Key Players Opioid Induced Constipation Drugs Revenue Share in United States (2015-2020)
Table 121. North America Opioid Induced Constipation Drugs Revenue (USD Million) by Countries (2015-2020)
Table 122. North America Opioid Induced Constipation Drugs Revenue Market Share by Countries (2015-2020)
Table 123. North America Opioid Induced Constipation Drugs Revenue (USD Million) by Countries (2020-2026)
Table 124. North America Opioid Induced Constipation Drugs Revenue Market Share by Countries (2020-2026)
Table 125. Europe Opioid Induced Constipation Drugs Revenue (USD Million) by Countries (2015-2020)
Table 126. Europe Opioid Induced Constipation Drugs Revenue Market Share by Countries (2015-2020)
Table 127. Europe Opioid Induced Constipation Drugs Revenue (USD Million) by Countries (2020-2026)
Table 128. Europe Opioid Induced Constipation Drugs Revenue Market Share by Countries (2020-2026)
Table 129. Asia-Pacific Opioid Induced Constipation Drugs Revenue (USD Million) by Countries (2015-2020)
Table 130. Asia-Pacific Opioid Induced Constipation Drugs Revenue Market Share by Countries (2015-2020)
Table 131. Asia-Pacific Opioid Induced Constipation Drugs Revenue (USD Million) by Countries (2020-2026)
Table 132. Asia-Pacific Opioid Induced Constipation Drugs Revenue Market Share by Countries (2020-2026)
Table 133. South America Opioid Induced Constipation Drugs Revenue (USD Million) by Countries (2015-2020)
Table 134. South America Opioid Induced Constipation Drugs Revenue Market Share by Countries (2015-2020)
Table 135. South America Opioid Induced Constipation Drugs Revenue (USD Million) by Countries (2020-2026)
Table 136. South America Opioid Induced Constipation Drugs Revenue Market Share by Countries (2020-2026)
Table 137. Middle East & Africa Opioid Induced Constipation Drugs Revenue (USD Million) by Countries (2015-2020)
Table 138. Middle East & Africa Opioid Induced Constipation Drugs Revenue Market Share by Countries (2015-2020)
Table 139. Middle East & Africa Opioid Induced Constipation Drugs Revenue (USD Million) by Countries (2020-2026)
Table 140. Middle East & Africa Opioid Induced Constipation Drugs Revenue Market Share by Countries (2020-2026)
Table 141. Global Opioid Induced Constipation Drugs Revenue (USD Million) by Type (2015-2020)
Table 142. Global Opioid Induced Constipation Drugs Revenue Share by Type (2015-2020)
Table 143. Global Opioid Induced Constipation Drugs Revenue Forecast by Type (2020-2025)
Table 144. Global Opioid Induced Constipation Drugs Market Share Forecast by Type (2020-2025)
Table 145. United States Opioid Induced Constipation Drugs Revenue (USD Million) by Type (2015-2020)
Table 146. United States Opioid Induced Constipation Drugs Revenue Share by Type (2015-2020)
Table 147. United States Opioid Induced Constipation Drugs Revenue Forecast by Type (2020-2025)
Table 148. United States Opioid Induced Constipation Drugs Market Share Forecast by Type (2020-2025)
Table 149. Global Opioid Induced Constipation Drugs Revenue (USD Million) by Application (2015-2020)
Table 150. Global Opioid Induced Constipation Drugs Revenue Share by Application (2015-2020)
Table 151. Global Opioid Induced Constipation Drugs Revenue Forecast by Application (2020-2025)
Table 152. Global Opioid Induced Constipation Drugs Market Share Forecast by Application (2020-2025)
Table 153. United States Opioid Induced Constipation Drugs Revenue (USD Million) by Application (2015-2020)
Table 154. United States Opioid Induced Constipation Drugs Revenue Share by Application (2015-2020)
Table 155. United States Opioid Induced Constipation Drugs Revenue Forecast by Application (2020-2025)
Table 156. United States Opioid Induced Constipation Drugs Market Share Forecast by Application (2020-2025)
List of Figures
Figure 1. Opioid Induced Constipation Drugs Picture
Figure 2. Global Opioid Induced Constipation Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Global Opioid Induced Constipation Drugs Revenue Market Share by Type in 2019
Figure 4. Lubiprostone Picture
Figure 5. Methyl Naltrexone Bromide Picture
Figure 6. Naldemedine Picture
Figure 7. Alvimopan Picture
Figure 8. Other Picture
Figure 9. Opioid Induced Constipation Drugs Revenue Market Share by Application in 2019
Figure 10. Hospital Pharmacies Picture
Figure 11. Retail Pharmacies Picture
Figure 12. Online Pharmacies Picture
Figure 13. Global Opioid Induced Constipation Drugs Revenue and Growth Rate (2015-2025) (USD Million)
Figure 14. Global Opioid Induced Constipation Drugs Market Size Share by Regions (2015-2025)
Figure 15. Global Opioid Induced Constipation Drugs Market Size Share by Regions in 2019
Figure 16. Global Opioid Induced Constipation Drugs Revenue Market Share by Regions (2020-2025)
Figure 17. North America Opioid Induced Constipation Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 18. Europe Opioid Induced Constipation Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 19. Asia-Pacific Opioid Induced Constipation Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 20. South America Opioid Induced Constipation Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 21. Middle East & Africa Opioid Induced Constipation Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 22. Global Opioid Induced Constipation Drugs Revenue Share by Players in 2019
Figure 23. Global Top 5 Players Opioid Induced Constipation Drugs Revenue Market Share in 2019
Figure 24. Top 10 Players Opioid Induced Constipation Drugs Revenue Market Share in Global Market in 2019
Figure 25. Global Opioid Induced Constipation Drugs Market Size (USD Million) by Type (2015-2025)
Figure 26. Global Opioid Induced Constipation Drugs Market Size Share by Application (2015-2025)
Figure 27. North America Opioid Induced Constipation Drugs Market Size Share by Countries (2015-2025)
Figure 28. North America Opioid Induced Constipation Drugs Market Size Share by Countries in 2019
Figure 29. United States Opioid Induced Constipation Drugs Market Size (USD Million) and Forecast (2015-2025)
Figure 30. Canada Opioid Induced Constipation Drugs Market Size (USD Million) and Forecast (2015-2025)
Figure 31. Mexico Opioid Induced Constipation Drugs Market Size (USD Million) and Forecast (2015-2025)
Figure 32. Europe Opioid Induced Constipation Drugs Market Size Share by Countries (2015-2025)
Figure 33. Europe Opioid Induced Constipation Drugs Market Size Share by Countries in 2019
Figure 34. Germany Opioid Induced Constipation Drugs Market Size (USD Million) and Forecast (2015-2025)
Figure 35. France Opioid Induced Constipation Drugs Market Size (USD Million) and Forecast (2015-2025)
Figure 36. Russia Opioid Induced Constipation Drugs Market Size (USD Million) and Forecast (2015-2025)
Figure 37. Italy Opioid Induced Constipation Drugs Market Size (USD Million) and Forecast (2015-2025)
Figure 38. Spain Opioid Induced Constipation Drugs Market Size (USD Million) and Forecast (2015-2025)
Figure 39. UK Opioid Induced Constipation Drugs Market Size (USD Million) and Forecast (2015-2025)
Figure 40. Asia Opioid Induced Constipation Drugs Market Size Share by Countries (2015-2025)
Figure 41. Asia Opioid Induced Constipation Drugs Market Size Share by Countries in 2019
Figure 42. China Opioid Induced Constipation Drugs Market Size (USD Million) and Forecast (2015-2025)
Figure 43. Japan Opioid Induced Constipation Drugs Market Size (USD Million) and Forecast (2015-2025)
Figure 44. Korea Opioid Induced Constipation Drugs Market Size (USD Million) and Forecast (2015-2025)
Figure 45. India Opioid Induced Constipation Drugs Market Size (USD Million) and Forecast (2015-2025)
Figure 46. Southeast Asia Opioid Induced Constipation Drugs Market Size (USD Million) and Forecast (2015-2025)
Figure 47. South America Opioid Induced Constipation Drugs Market Size Share by Countries (2015-2025)
Figure 48. South America Opioid Induced Constipation Drugs Market Size Share by Countries in 2019
Figure 49. Brazil Opioid Induced Constipation Drugs Market Size (USD Million) and Forecast (2015-2025)
Figure 50. Argentina Opioid Induced Constipation Drugs Market Size (USD Million) and Forecast (2015-2025)
Figure 51. Middle East & Africa Opioid Induced Constipation Drugs Market Size Share by Countries (2015-2025)
Figure 52. Middle East & Africa Opioid Induced Constipation Drugs Market Size Share by Countries in 2019
Figure 53. Saudi Arabia Opioid Induced Constipation Drugs Market Size (USD Million) and Forecast (2015-2025)
Figure 54. UAE Opioid Induced Constipation Drugs Market Size (USD Million) and Forecast (2015-2025)
Figure 55. Egypt Opioid Induced Constipation Drugs Market Size (USD Million) and Forecast (2015-2025)
Figure 56. South Africa Opioid Induced Constipation Drugs Market Size (USD Million) and Forecast (2015-2025)
Figure 57. Global Opioid Induced Constipation Drugs Revenue Share by Type (2015-2020)
Figure 58. United States Opioid Induced Constipation Drugs Revenue Share by Type (2015-2020)
Figure 59. Global Opioid Induced Constipation Drugs Revenue Share by Application (2015-2020)
Figure 60. United States Opioid Induced Constipation Drugs Revenue Share by Application (2015-2020)
Please feel free to write an email to us or to use our electronic ticketing system.
